Skip to main content
OpenTrials

Clinical trial condition

Non-Muscle Invasive Bladder Neoplasms

Explore clinical trials studying Non-Muscle Invasive Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

195 public trials 69 recruiting studies
Refine in advanced search Browse all conditions

Non-Muscle Invasive Bladder Neoplasms trial results

Completed

Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer

NCT00782587

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • BCG Oncology, PC Phoenix, Arizona, United States
  • Advanced Urology Medical Center Anaheim, California, United States
  • Medresearch La Mesa, California, United States
  • Malcolm Randall Veterans Administration Gainesville, Florida, United States
View Trial Details
Completed

A Randomized Study Comparing Single Agent Gemcitabine Intravesical Therapy Versus Mitomycin C in Patients With Intermediate Risk Superficial Bladder Cancer

NCT00192049

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Beersheba, Israel
  • For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Haifa, Israel
  • For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Jerusalem, Israel
  • For additional information regarding investigative sites for this trial contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your personal physician Kfar Saba, Israel
View Trial Details
Completed

Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.

NCT00191711

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern time (UTC/GMT - 5 hours, EST) or speak with your physician Sesto Fiorentino, Florence, Italy
View Trial Details
Active, Not Recruiting

Intravesical BCG vs GEMDOCE in NMIBC

NCT05538663

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 229 locations
View Trial Details
Active, Not Recruiting

Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the Bladder

NCT03317158

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
Locations
  • BCG Oncology Phoenix, Arizona, United States
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
  • Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
View Trial Details

Related conditions